Shalini Singh Mbbs MD PhD
About Shalini Singh Mbbs MD PhD
Shalini Singh is a Senior Medical Director at Adaptimmune, with extensive experience in oncology and clinical trials. She has held various roles in prominent organizations such as Novartis, Pfizer, and Cancer Research UK, and has a strong academic background with an MD, PhD, and studies in medical statistics and organizational leadership.
Work at Adaptimmune
Shalini Singh serves as the Senior Medical Director at Adaptimmune, a role she has held since 2021. In this position, she is responsible for overseeing medical strategies and initiatives within the organization. Her extensive background in oncology and clinical trials supports her leadership in developing innovative therapies. Adaptimmune focuses on cell therapy to treat cancer, and Singh's expertise contributes to advancing the company's mission.
Previous Experience at Novartis
Prior to her current role, Shalini Singh worked at Novartis as a Global Medical Expert from 2012 to 2014. During her tenure in Horsham, UK, she contributed to the development and implementation of medical strategies that aligned with the company's objectives in oncology. This experience enhanced her understanding of global medical affairs and the pharmaceutical landscape.
Education and Expertise
Shalini Singh's educational background includes a Medical Doctor (MD) degree from G. S. Medical School and KEM Hospital, Mumbai University, and a PhD in Oncology from Queen Mary, University of London. She also completed an Intensive Course in Medical Statistics at the London School of Hygiene and Tropical Medicine. Additionally, she pursued a Short Course in Organizational Leadership at The London School of Economics and Political Science (LSE). This diverse education underpins her expertise in oncology and medical statistics.
Clinical Trial Leadership Experience
Shalini Singh has extensive experience leading clinical trials across multiple continents, including the US, UK, Europe, Asia, Brazil, Russia, and China. Her role as a Trial Physician at Cancer Research UK and as a Lead Clinician at Pfizer contributed to her proficiency in managing complex clinical studies. She has been involved in pioneering programs in various medical fields, including cancer and inflammation, demonstrating her capability in advancing clinical research.
Publications and Scientific Contributions
Shalini Singh has a proven track record of presenting scientific work at conferences and has published five papers in reputable journals, including Br J Haematology, Lancet Oncology, and Breast Cancer Research Treatment. Her contributions to the scientific community reflect her commitment to advancing knowledge in oncology and related fields. Singh's research has addressed critical issues in cancer treatment and patient care.